— Know what they know.
Not Investment Advice

AUGX NASDAQ

Augmedix, Inc.
1W: +0.4% 1M: +1.7% 3M: +135.0% 1Y: -55.3% 3Y: -55.2%
$2.35
Last traded 2024-10-02 — delisted
NASDAQ · Healthcare · Medical - Healthcare Information Services · $115.9M mcap · 25M float · 3.22% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$115.9M
52W Range0.73-6.25
Volume22,995
Avg Volume805,583
Beta-0.19
Dividend—
Analyst Ratings
4 Buy 2 Hold 0 Sell
Consensus Buy
Company Info
CEOEmmanuel Krakaris
Employees1,430
SectorHealthcare
IndustryMedical - Healthcare Information Services
IPO Date2021-03-31
111 Sutter Street
San Francisco, CA 94104
US
888 669 4885
About Augmedix, Inc.

Augmedix, Inc. is a U.S.-based company specializing in remote medical documentation and offering live support to clinical professionals. Its comprehensive platform, comprising Augmedix Live and Augmedix Notes, streamlines the entire documentation process for patient encounters. This includes preparatory tasks like pre-charting and digitizing historical patient data prior to appointments. During the consultation, it generates essential medical notes, flags care gaps, provides HCC reminders, and produces after-visit summaries. Post-visit, the system facilitates crucial administrative duties such as medical coding, processing orders, and managing referrals. Clinicians can readily access these applications via mobile devices, including smartphones or specialized wearables like Google Glass. The company's clientele primarily consists of various health systems and distinct specialty groups. Founded in 2013, Augmedix maintains its corporate headquarters in San Francisco, California.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Redmile Group, LLC D-Return 6,218,238 $2.35 2024-10-02
Redmile Group, LLC D-Return 1,093,799 $1.75 2024-10-02
Faulkner Robert C. D-Return 41,461 $2.35 2024-10-02
FEBBO WILLIAM J D-Return 50,000 $2.80 2024-10-02
FEBBO WILLIAM J D-Return 162,583 $2.35 2024-10-02

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms